ISCD Learning
DXA in Children Treated with Bisphosphonates
-
Register
- Non-Member - $25
- Full Member - Free!
- MOC Only - Free!
- Community Member - $25
- Professional Member - Free!
Activity approved for up to 1.00 AMA PRA Category 1 Credits™
Activity approved for 1.5 ASRT Category A Credits
Activity Expires August 14, 2026
Activity Description
In growing bone, administration of bisphosphonate yields differing effects based on medical condition, age, skeletal site measured, and therapeutic regimen. This session will show how to identify these effects.
Learning Objectives:
- Describe appearance of bisphosphonate treatment at measured body sites in treated children.
- Examine BP treatment effects over time in children with different conditions.
- Review bisphosphonate treatment approaches used in pediatrics.
Instructions:
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on August 15, 2025.
Heidi Kecskemethy, MS Ed, RDN, CSP, CBDT
Director of Radiology Research Operations
Nemours Children's Health
Heidi Kecskemethy, MS Ed, RDN, CBDT is the Enterprise Director of Radiology Research and is a Clinical Research Scientist at Nemours Children’s Health. She is based at Nemours Children’s Hospital Delaware in Wilmington, DE, USA. She has been certified by the ISCD since 2002, has served on various committees including chairing the Pediatric Committee, has served on two Pediatric Positions Development Committees (2013 and 2019), and is a past member of the ISCD Board.
Her scientific expertise is in pediatric nutrition and bone densitometry, with emphasis on bone assessment in patients with neuromuscular disabilities. She regularly presents at national and international meetings and has traveled the world providing instruction to healthcare professionals on pediatric bone assessment and the lateral distal femur DXA technique. She serves as a resource and educator for clinicians and researchers, providing guidance on pediatric bone density assessment and quality, and the conduct and design of human subject research. Heidi is also a Registered Dietitian with Board Certification in Pediatric Nutrition and has authored or co-authored over 40 peer-reviewed papers and 8 book chapters.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
